What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Chemotherapy
Franco Mandelli focuses on Internal medicine, Surgery, Leukemia, Chemotherapy and Gastroenterology.
His research integrates issues of Acute promyelocytic leukemia and Oncology in his study of Internal medicine.
His work on Bone marrow expands to the thematically related Surgery.
The study incorporates disciplines such as Myeloid and Cancer research in addition to Leukemia.
Franco Mandelli interconnects Regimen, Prednisone and Lymphoma in the investigation of issues within Chemotherapy.
His studies in Gastroenterology integrate themes in fields like Maintenance therapy, Pathology, Induction chemotherapy, Alpha interferon and Multiple myeloma.
His most cited work include:
- Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype (1395 citations)
- Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study (1065 citations)
- Retinoic acid and arsenic trioxide for acute promyelocytic leukemia (834 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Surgery, Gastroenterology, Leukemia and Chemotherapy.
His biological study spans a wide range of topics, including Immunology and Oncology.
Surgery connects with themes related to Bone marrow in his study.
His Gastroenterology research incorporates themes from Alpha interferon, Toxicity and Pathology.
The various areas that he examines in his Leukemia study include Acute promyelocytic leukemia and Myeloid.
His work deals with themes such as Radiation therapy, Acute lymphocytic leukemia and Lymphoma, which intersect with Chemotherapy.
He most often published in these fields:
- Internal medicine (59.86%)
- Surgery (28.52%)
- Gastroenterology (25.23%)
What were the highlights of his more recent work (between 2008-2020)?
- Internal medicine (59.86%)
- Quality of life (4.81%)
- Surgery (28.52%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Quality of life, Surgery, Oncology and Leukemia.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Immunology and Acute promyelocytic leukemia.
His Acute promyelocytic leukemia research integrates issues from Idarubicin and Tretinoin.
His work carried out in the field of Quality of life brings together such families of science as Observational study, Myelodysplastic syndromes, Physical therapy, Pediatrics and Comorbidity.
His Surgery research is multidisciplinary, incorporating perspectives in Interferon, Incidence and Toxicity.
His Leukemia research is multidisciplinary, relying on both Myeloid, Cancer research, Clinical trial and Induction chemotherapy.
Between 2008 and 2020, his most popular works were:
- Retinoic acid and arsenic trioxide for acute promyelocytic leukemia (834 citations)
- Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia (270 citations)
- Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group (238 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Franco Mandelli mainly investigates Internal medicine, Myeloid leukemia, Quality of life, Leukemia and Surgery.
His work in Internal medicine addresses subjects such as Oncology, which are connected to disciplines such as Etoposide.
His work on Imatinib as part of general Myeloid leukemia research is frequently linked to Social support, bridging the gap between disciplines.
His Quality of life research incorporates elements of Observational study, MEDLINE, Psychiatry, Intensive care medicine and Myelodysplastic syndromes.
His Leukemia study incorporates themes from Acute promyelocytic leukemia, Hematology, Randomized controlled trial, Tretinoin and Induction chemotherapy.
His research in Surgery intersects with topics in Gastroenterology, Incidence and Toxicity.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
